Rheumatology and COVID-19 at 1 year: facing the unknowns
- PMID: 33658236
- PMCID: PMC8142424
- DOI: 10.1136/annrheumdis-2021-219957
Rheumatology and COVID-19 at 1 year: facing the unknowns
Keywords: autoimmunity; covid-19; inflammation; vaccination.
Conflict of interest statement
Competing interests: None declared.
Figures
Comment on
-
EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19.Ann Rheum Dis. 2021 Jun;80(6):698-706. doi: 10.1136/annrheumdis-2020-219724. Epub 2021 Feb 5. Ann Rheum Dis. 2021. PMID: 33547062 Free PMC article.
-
Immunomodulatory therapies for SARS-CoV-2 infection: a systematic literature review to inform EULAR points to consider.Ann Rheum Dis. 2021 Jun;80(6):803-815. doi: 10.1136/annrheumdis-2020-219725. Epub 2021 Feb 15. Ann Rheum Dis. 2021. PMID: 33589438 Free PMC article.
References
-
- COVID-19 Real time learning network . Cdc and infectious disease Society of America, 2021. Available: https://www.idsociety.org/covid-19-real-time-learning-network/vaccines/v...
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
